Arcus Biosciences Inc (RCUS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
3,140,556,000
EV to revenue ratio (TTM)
23.7
EV to ebitda
3.96
Financial Performance
Revenue (TTM)
117,000,000
Gross profit (TTM)
-380,000,000
EBITDA
-476,000,000
Profitability
Operating margin (TTM)
-234.10%
Profit margin
0.00%
Return on assets (TTM)
-30.40%
Return on equity (TTM)
-90.80%
Per Share Metrics
Revenue per share (TTM)
0.98
EPS
-3.94
Diluted EPS (TTM)
-3.94
Book value
3.65
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
26.84
Price to book ratio (TTM)
7.24
Growth
Quarterly earnings growth (YoY)
-74.40%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
10
Hold
3
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.812